Severity
Moderate
ModerateActive
CPSC recall · Reported July 6, 2018
Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Sandoz Inc., of Princeton, N.j. recalled This recall involves blister packages of prescription drugs from Novartis and Sandoz. The… - a moderate-severity action.
Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Chil… was recalled by Sandoz Inc., of Princeton, N.j. in July 6, 2018. Reason: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, po…. Remedy: Consumers should immediately secure the blister cards to keep them out of the sight and r…. Verify recall #18183 with the CPSC before acting.
The recall
Sandoz Inc., of Princeton, N.j. issued this moderate-severity CPSC recall-The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, po….
- Moderate
- severity level
- July 6, 2018
- reported
Sourced from official CPSC enforcement records. Verify recall #18183 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #18183) was formally reported on July 6, 2018. It is classified under Moderate severity, with a current status of Active. Sandoz Inc., of Princeton, N.j. is listed as the recalling firm. Federal records list the affected scope as About 470,000.
The documented reason for this recall is: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that cons… - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
About 470,000
Related Recalls
6
0 from same agency
Product description
This recall involves blister packages of prescription drugs from Novartis and Sandoz. The drugs are packaged with 3 to 10 tablets per blister card. The recalled Novartis prescription blister packages have "Novartis," the name of the drug, dosage, NDC, lot number and expiration date printed on the cartons and the blister cards. The recall includes the following: Recalled Novartis Prescription Drugs NDC Numbers Tablet Strength Carton Configuration Lot Numbers Expiration Date Zofran ODT® 0078-0679-61 0078-0679-19 4 mg 30 count: 3 cards with 10 tablets each 1657088 Dec 2019 Zofran ODT® 0078-0680-61 0078-0680-19 8 mg 30 count: 3 cards with 10 tablets each 1641546 Oct 2019 Entresto® (sacubitril/valsartan) 0078-0659-61 0078-0659-35 24 mg/ 26 mg 100 count: 10 cards with 10 tablets each FX000005 FX000004 FX000003 F0010 F0009 F0007 Apr 2020 Apr 2020 Sep 2019 Nov 2018 Aug 2018 Jul 2018 Entresto® (sacubitril/valsartan) 0078-0777-61 0078-0777-35 49 mg/ 51 mg 100 count: 10 cards with 10 tablets each FX000001 F0006 F0005 F0004 Dec 2019 Oct 2019 Aug 2019 Oct 2018 Entresto® (sacubitril/valsartan) 0078-0696-61 0078-0696-35 97 mg/ 103 mg 100 count: 10 cards with 10 tablets each FX000002 F0007 F0006 F0005 F0004 Mar 2020 Feb 2020 Dec 2019 Dec 2018 Oct 2018 The recalled Sandoz prescription blister packages have "Sandoz," the name of the drug, dosage, NDC and lot number printed on the cartons and the blister cards. Lot numbers are listed at www.us.sandoz.com/patients-customers/product-safety-notices. The recall includes the following: Recalled Sandoz Prescription Drugs Tablet Strength NDC Numbers Carton Configuration Azithromycin Tablets 250 mg 0781-5776-06 0781-5776-69 50 count: 5 cards with 10 tablets each Donepezil ODT Tablets 5 mg 0781-5276-06 0781-5276-64 30 count: 3 cards with 10 tablets each Donepezil ODT Tablets 10 mg 0781-5277-06 0781-5277-64 30 count: 3 cards with 10 tablets each Haloperidol Tablets 0.5 mg 0781-1391-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 1 mg 0781-1392-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 2 mg 0781-1393-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 5 mg 0781-1396-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 10 mg 0781-1397-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 25 mg 0781-1764-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 50 mg 0781-1766-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 10 mg 0781-1556-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 20 mg 0781-1695-13 100 count: 10 cards with 10 tablets each Naratriptan Tablets 2.5 mg 0781-5527-06 0781-5527-37 9 count: 1 card with 9 tablets Ondansetron Tablets 8 mg 0781-1681-33 3 count: 1 card with 3 tablets Ondansetron ODT 4 mg 0781-5238-06 0781-5238-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-80 10 count: 1 card with 10 tablets Perphenazine Tablets 2 mg 0781-1046-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 4 mg 0781-1047-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 8 mg 0781-1048-13 100 count: 10 cards with 10 tablets each Risperidone ODT 0.5 mg 0781-5310-06 0781-5310-08 28 count: 7 cards with 4 tablets each Risperidone ODT 1 mg 0781-5311-06 0781-5311-08 28 count: 7 cards with 4 tablets each Risperidone ODT 2 mg 0781-5312-06 0781-5312-08 28 count: 7 cards with 4 tablets each Risperidone ODT 3 mg 0781-5313-06 0781-5313-08 28 count: 7 cards with 4 tablets each Risperidone ODT 4 mg 0781-5314-06 0781-5314-08 28 count: 7 cards with 4 tablets each
Reason for recall
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Remedy, what to do
Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 18183 |
| Date reported | July 6, 2018 |
| Date initiated | July 6, 2018 |
| Recalling firm | Sandoz Inc., of Princeton, N.j. |
| Affected scope | About 470,000 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or…
- Check the recall number (18183) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
This recall involves blister packages of prescription drugs from Novartis and Sandoz. The drugs are packaged with 3 to 10 tablets per blister card. The recalled Novartis prescription blister packages have "Novartis," the name of the drug, dosage, NDC, lot number and expiration date printed on the cartons and the blister cards. The recall includes the following: Recalled Novartis Prescription Drugs NDC Numbers Tablet Strength Carton Configuration Lot Numbers Expiration Date Zofran ODT® 0078-0679-61 0078-0679-19 4 mg 30 count: 3 cards with 10 tablets each 1657088 Dec 2019 Zofran ODT® 0078-0680-61 0078-0680-19 8 mg 30 count: 3 cards with 10 tablets each 1641546 Oct 2019 Entresto® (sacubitril/valsartan) 0078-0659-61 0078-0659-35 24 mg/ 26 mg 100 count: 10 cards with 10 tablets each FX000005 FX000004 FX000003 F0010 F0009 F0007 Apr 2020 Apr 2020 Sep 2019 Nov 2018 Aug 2018 Jul 2018 Entresto® (sacubitril/valsartan) 0078-0777-61 0078-0777-35 49 mg/ 51 mg 100 count: 10 cards with 10 tablets each FX000001 F0006 F0005 F0004 Dec 2019 Oct 2019 Aug 2019 Oct 2018 Entresto® (sacubitril/valsartan) 0078-0696-61 0078-0696-35 97 mg/ 103 mg 100 count: 10 cards with 10 tablets each FX000002 F0007 F0006 F0005 F0004 Mar 2020 Feb 2020 Dec 2019 Dec 2018 Oct 2018 The recalled Sandoz prescription blister packages have "Sandoz," the name of the drug, dosage, NDC and lot number printed on the cartons and the blister cards. Lot numbers are listed at www.us.sandoz.com/patients-customers/product-safety-notices. The recall includes the following: Recalled Sandoz Prescription Drugs Tablet Strength NDC Numbers Carton Configuration Azithromycin Tablets 250 mg 0781-5776-06 0781-5776-69 50 count: 5 cards with 10 tablets each Donepezil ODT Tablets 5 mg 0781-5276-06 0781-5276-64 30 count: 3 cards with 10 tablets each Donepezil ODT Tablets 10 mg 0781-5277-06 0781-5277-64 30 count: 3 cards with 10 tablets each Haloperidol Tablets 0.5 mg 0781-1391-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 1 mg 0781-1392-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 2 mg 0781-1393-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 5 mg 0781-1396-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 10 mg 0781-1397-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 25 mg 0781-1764-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 50 mg 0781-1766-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 10 mg 0781-1556-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 20 mg 0781-1695-13 100 count: 10 cards with 10 tablets each Naratriptan Tablets 2.5 mg 0781-5527-06 0781-5527-37 9 count: 1 card with 9 tablets Ondansetron Tablets 8 mg 0781-1681-33 3 count: 1 card with 3 tablets Ondansetron ODT 4 mg 0781-5238-06 0781-5238-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-80 10 count: 1 card with 10 tablets Perphenazine Tablets 2 mg 0781-1046-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 4 mg 0781-1047-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 8 mg 0781-1048-13 100 count: 10 cards with 10 tablets each Risperidone ODT 0.5 mg 0781-5310-06 0781-5310-08 28 count: 7 cards with 4 tablets each Risperidone ODT 1 mg 0781-5311-06 0781-5311-08 28 count: 7 cards with 4 tablets each Risperidone ODT 2 mg 0781-5312-06 0781-5312-08 28 count: 7 cards with 4 tablets each Risperidone ODT 3 mg 0781-5313-06 0781-5313-08 28 count: 7 cards with 4 tablets each Risperidone ODT 4 mg 0781-5314-06 0781-5314-08 28 count: 7 cards with 4 tablets each. Recalled by Sandoz Inc., of Princeton, N.j.. Units affected: About 470,000.
Why was this product recalled? ▼
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
What should consumers do? ▼
Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.
Which agency issued this recall? ▼
This recall was issued by the CPSC on July 6, 2018. Severity: Moderate. Recall number: 18183.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (18183) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
FDA Drug Low
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie c…
AbbVie Inc. · 2026-06-03
FDA Food Moderate
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bot…
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
FDA Drug Moderate
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:…
Safecor Health, LLC · 2026-05-27
FDA Drug Moderate
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3…
IntegraDose Compounding Services LLC · 2026-05-27
FDA Drug Moderate
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, …
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported July 6, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.